Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma

Cancer

Volumn 104, Issue 8, 2005, Pages 1765-1771

  Spring, Paul M ^a,c   Valentino, Joseph ^a   Arnold, Susanne M ^a,b   Sloan, David ^a   Kenady, Daniel ^a   Kudrimoti, Mahesh ^a   Haydon III, Richard C ^a   Lee, Charles ^a   Given, Curtis ^a   Mohiuddin, Mohammed ^a   Regine, William F ^a,d  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperfractionated; Hyperfractionated radiation and high dose intraarterial cisplatin; Intraarterial; Multimodality; Oropharynx; Unresectable

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEEDING APPARATUS; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; LONG TERM CARE; LUNG METASTASIS; LYMPH NODE; MALE; MORBIDITY; MUCOSA INFLAMMATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE; THIOSULFATES; TIME FACTORS;

EID: 26444459736     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21368     Document Type: Article

References (27)

1. Decker DA, Drelichman A, Jacobs J, et al. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer. 1983;51:1353-1355.
2. Calais G, Garand G, Beutter P, Le Floch O. [Advanced carcinoma of the oropharynx: the value of induction chemotherapy before locoregional treatment. A retrospective study of 138 cases]. Bull Cancer. 1988;75:971-978.
3. Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer. 2000;83:1594-1598.
4. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
5. Robbins KT, Storniolo AM, Kerber C, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994;12:2113-2120.
6. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263-271.
7. Regine WF, Valentino J, Arnold SM, et al. A Phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. Technol Cancer Res Treat. 2002;1:133-140.
8. Regine WF, Valentino J, Arnold SM, et al. High-dose intraarterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 2001;19:3333-3339.
9. Regine WF, Valentino J, John W, et al. High-dose intraarterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: report of a Phase II study. Head Neck. 2000;22:543-549.
10. Kaplan E, Meier, P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1953;53:475-481.
11. Adelstein DJ, Saxton JP, Lavertu P, et al. A Phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable Stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck. 1997;19:567-575.
12. Brizel DM. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol. 1998;8:237-246.
13. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
14. Kusano S, Katayama M, Uematsu M, et al. Intraarterial infusion of dibutyryl cyclic adenosine monophosphate plus mitomycin C for unresectable hepatocellular carcinoma: long-term survival and response to tumor growth inhibition. Acad Radiol. 1995;2:286-292.
15. Hamana S, Motoyama S, Takeuchi S, et al. Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum. Am J Clin Oncol. 2001;24:241-246.
16. Jacobs SC, Menashe DS, Mewissen MW, Lipchik EO. Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladder. Cancer. 1989;64:388-391.
17. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck. 1992;14:364-371.
18. Kumar P, Robbins KT, Harris J, et al. Intra-arterial (IA) cisplatin (P) and radiation therapy (RT) is feasible in a multi-institutional setting for the treatment of Stage IV-T4 head/neck (H/N) squamous cell carcinoma (SCCa): initial results of Radiation Therapy Oncology Group (RTOG) Trial 9615. Proceedings of the American Society for Clinical Oncology (ASCO), San Francisco, California [abstract 918]. J Clin Oncol. 2001;20:230a.
19. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685-1690.
20. Garden AS, Glisson BS, Ang KK, et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol. 1999;17:2390-2395.
21. Kies MS, Haraf DJ, Athanasiadis I, et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol. 1998;16:2715-2721.
22. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953-959.
23. Jones AS, Bin Hanafi Z, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996;74:128-132.
24. Agra IM, Carvalho AL, Pontes E, et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129:1317-1321.
25. De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 2001;91:2071-2076.
26. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000;110(3 Pt 2 Suppl 93):1-18.
27. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol, 2000;18:1458-1464.